JETBLUE AIRWAYS CORP (JBLU)
US4771431016 - Common Stock
Overall JBLU gets a fundamental rating of 2 out of 10. We evaluated JBLU against 24 industry peers in the Passenger Airlines industry. Both the profitability and financial health of JBLU have multiple concerns. JBLU does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year JBLU has reported negative net income.
In the past year JBLU had a positive cash flow from operations.
In the past 5 years JBLU reported 4 times negative net income.
JBLU had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
JBLU's Return On Assets of -5.14% is in line compared to the rest of the industry. JBLU outperforms 45.83% of its industry peers.
With a Return On Equity value of -32.30%, JBLU perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.14% | ||
| ROE | -32.3% | ||
| ROIC | N/A |
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
JBLU's Gross Margin of 64.75% is fine compared to the rest of the industry. JBLU outperforms 79.17% of its industry peers.
In the last couple of years the Gross Margin of JBLU has remained more or less at the same level.
JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%
2. Health
2.1 Basic Checks
JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JBLU has been increased compared to 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
Compared to 1 year ago, JBLU has a worse debt to assets ratio.
2.2 Solvency
JBLU has an Altman-Z score of 0.81. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of JBLU (0.81) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.98 is on the high side and indicates that JBLU has dependencies on debt financing.
JBLU has a Debt to Equity ratio (2.98) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.98 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.81 |
ROIC/WACCN/A
WACC6.03%
2.3 Liquidity
JBLU has a Current Ratio of 1.21. This is a normal value and indicates that JBLU is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of JBLU (1.21) is better than 91.67% of its industry peers.
A Quick Ratio of 1.18 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU's Quick ratio of 1.18 is amongst the best of the industry. JBLU outperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1066.67%.
JBLU shows a decrease in Revenue. In the last year, the revenue decreased by -3.90%.
JBLU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.66% yearly.
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.97%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Sales Q2Q%0.51%
3.2 Future
Based on estimates for the next years, JBLU will show a very strong growth in Earnings Per Share. The EPS will grow by 30.49% on average per year.
JBLU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.05% yearly.
EPS Next Y-95.52%
EPS Next 2Y-12.93%
EPS Next 3Y30.49%
EPS Next 5YN/A
Revenue Next Year-3.32%
Revenue Next 2Y1.02%
Revenue Next 3Y3.05%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for JBLU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of JBLU is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.56 |
4.3 Compensation for Growth
A more expensive valuation may be justified as JBLU's earnings are expected to grow with 30.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.93%
EPS Next 3Y30.49%
5. Dividend
5.1 Amount
No dividends for JBLU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
JETBLUE AIRWAYS CORP
NASDAQ:JBLU (11/18/2024, 2:27:05 PM)
6.465
-0.59 (-8.43%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.24B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.14% | ||
| ROE | -32.3% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.75% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.98 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-95.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y